The Prostate Cancer Study throughout Life (PROCA-life) investigating potential relationship between high sensitive CRP (hs-CRP) levels and white blood cell count (WBC) demonstrated that a significant increase in hs-CPR levels was associated with high PCa risks. This evidence concerns the gene CRP and prostate cancer.